GlassScriptPhysician profile
Kimberly E Nicholson
NPI 1245636026
$378.93
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $308 · 2023: $39.17 · 2024: $32.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $64.13 | 2021-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $59.23 | 2021-2024 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $33.53 | 2021 | |
| Currax Pharmaceuticals LLC | $32.20 | 2021 | |
| Antares Pharma, INC. | $31.73 | 2021 | |
| Medtronic, INC. | $26.99 | 2021 | |
| Amneal Pharmaceuticals LLC | $26.85 | 2021 | |
| Zealand Pharma US, INC. | $23.09 | 2021 | |
| Novo Nordisk INC | $21.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.59 | 2021 | |
| Amarin Pharma, INC. | $15.55 | 2021 | |
| Lifescan, INC. | $11.81 | 2021 | |
| Glaxosmithkline, LLC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.